125 related articles for article (PubMed ID: 2950066)
21. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
[TBL] [Abstract][Full Text] [Related]
22. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
23. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
24. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
26. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
27. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
Fischer G; Wang S; Ahring S; Fowler K; Hainline S; Chinglong M; Jacques-Carroll L; Bell B; Williams I
Pediatr Infect Dis J; 2009 Jul; 28(7):593-7. PubMed ID: 19455073
[TBL] [Abstract][Full Text] [Related]
28. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B infection in sub-Saharan Africa. The African Regional Study Group.
Kiire CF
Vaccine; 1990 Mar; 8 Suppl():S107-12; discussion S134-8. PubMed ID: 2139278
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
[TBL] [Abstract][Full Text] [Related]
32. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
33. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu.
Wilson N; Ruff TA; Rana BJ; Leydon J; Locarnini S
Vaccine; 2000 Jul; 18(26):3059-66. PubMed ID: 10825610
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
[TBL] [Abstract][Full Text] [Related]
37. Global programme for control of hepatitis B infection.
Kane M
Vaccine; 1995; 13 Suppl 1():S47-9. PubMed ID: 7571830
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
[No Abstract] [Full Text] [Related]
39. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen-Positive Mothers - Guam, 2014.
Abara WE; Cha S; Malik T; DeSimone MS; Schumann B; Mallada E; Klemme M; Aguon V; Santos AM; Collier M; Kamb M
MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):506-508. PubMed ID: 28520708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
